PHOENIX, March 31,
2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:
SNES, "SenesTech" or the "Company"), a pioneer in fertility control
solutions for managing rodent populations, today announced
that it will participate in a webcast fireside chat at the
Lytham Partners 2025 Industrials & Basic Materials Investor
Summit, taking place virtually on Tuesday,
April 1, 2025.
The fireside chat will take place at 3:00
p.m. ET on Tuesday, April 1, 2025. The webcast can be
accessed by visiting the conference home page at
https://lythampartners.com/ibmsummit25/ or directly at
https://lythampartners.com/ibmsummit25/snes/. A replay of the
fireside chat will be available through the same links.
1x1 investor meetings will be available after the event upon
request by contacting a Lytham Partners representative at
1x1@lythampartners.com.
About SenesTech
SenesTech is committed to creating healthier environments by
humanely managing animal pest populations through fertility
control. The Company's groundbreaking products, including Evolve
rodent birth control, integrate seamlessly into pest management
programs, significantly enhancing their effectiveness while
reducing reliance on traditional poisons. SenesTech's mission is to
create cleaner cities, more efficient businesses, and healthier
communities with products that are humane, effective, and
sustainable.
For more information visit https://senestech.com/.
Safe Harbor Statement
This press release contains "forward-looking statements" within
the meaning of federal securities laws, and we intend that such
forward-looking statements be subject to the safe harbor created
thereby. Such forward-looking statements include, among others, our
expectation that a new case study will be published detailing the
success of Evolve in almond orchards, including a finding that by
slowly placing the Evolve bait further away from the trees it
actually lured the rats away from the crop altogether, highlighting
the rat's fondness for the fertility control product; our
expectation that our new optimization efforts will further reduce
expenses by $2 million on an annualized basis; our
anticipation that when coupled with lower cost of goods sold, the
new optimization efforts will reduce the revenue target for cash
flow breakeven to approximately $7 million annually,
compared to $12 million historically; our belief that
2024 has been a transformational year with strong financial
results; our belief that the increase in quarterly revenues and
quarterly gross margins, coupled with improvement in our
operational efficiencies through cost reduction resulted in our
smallest quarterly Adjusted EBITDA loss in Company history; our
belief that we are advancing towards profitability; our commitment
to execute a focused strategy that positions us for sustainable
long-term success; our belief that by concentrating on our most
impactful growth areas, improving cost-efficiency, and streamlining
operations, we are taking decisive steps to accelerate our path to
profitability; and our belief that we are well positioned to
transform the rodent control market for years to come due to our
first mover advantage with a disruptive approach to the
multi-billion dollar rodent control market.
Forward-looking statements may describe future expectations,
plans, results, or strategies and are often, but not always, made
through the use of words such as "believe," "may," "future,"
"plan," "will," "should," "expect," "anticipate," "eventually,"
"project," "estimate," "continuing," "intend" and similar words or
phrases. You are cautioned that such statements are subject to
risks, uncertainties and other factors that could cause actual
results to differ materially from those reflected by such
forward-looking statements. Such factors include, among others, the
successful commercialization of our products; market acceptance of
our products; our financial performance, including our ability to
fund operations; our ability to maintain compliance with Nasdaq's
continued listing requirements; regulatory approval and regulation
of our products; and other factors and risks identified from time
to time in our filings with the Securities and Exchange Commission,
including our Annual Report on Form 10-K for the fiscal year
ended December 31, 2024. All forward-looking statements
contained in this press release speak only as of the date on which
they were made and are based on management's assumptions and
estimates as of such date. Except as required by law, we do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investor Relations: Robert Blum, Lytham Partners, LLC,
602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer,
SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-participate-in-the-lytham-partners-2025-industrials--basic-materials-investor-summit-on-april-1-2025-302414591.html
SOURCE SenesTech, Inc.
